Mr. Okland joined Second Sight in March 2016 as Commercial Vice President, U.S., and Canada. Most recently he was president of Sanford Rose Associates–Okland Group, Inc., which specializes in commercial executive talent acquisition for early-stage to mid-cap medical device companies. Previously, he served as Vice President, Worldwide Marketing and Sales, at Miramar Labs, Inc., a medical device company targeting dermatologic medical conditions, where he led all commercialization activities. Prior to that, Mr. Okland served as Vice President, Worldwide Marketing and U.S. Sales at Medivance, Inc., and directed the turnaround of all commercialization activities, resulting in a $250M acquisition by Bard Medical. While at Spectranetics, Inc., as Vice President, U.S. Sales and Marketing, he directed all U.S. sales and marketing operations and the company was named to Fortune’s 100 Fastest Growing Companies three years in a row. He also held several sales positions of increasing responsibility for 12 years at Boston Scientific Corporation and at Johnson & Johnson Medical, Inc., where he began his career. He earned a Bachelor of Science degree from the University of Wisconsin and a Master of Business Administration from Texas Christian University.